POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

類似資料

• Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
  著者:: Van Gool, I, 等
  出版事項: (2018)
• POLE proofreading mutation, immune response and prognosis in endometrial cancer
  著者:: Van Gool, I, 等
  出版事項: (2015)
• A panoply of errors: polymerase proofreading domain mutations in cancer
  著者:: Rayner, E, 等
  出版事項: (2016)
• Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies
  著者:: Van Gool, I, 等
  出版事項: (2017)
• Practical guidance for mismatch repair-deficiency testing in endometrial cancer
  著者:: Stelloo, E, 等
  出版事項: (2016)